메뉴 건너뛰기




Volumn 2, Issue 1, 2007, Pages 21-25

Treatment interruption to boost specific HIV immunity in acute infection

Author keywords

Acute HIV infection; Antiviral therapy; CD4 T cell; CD8 T cell; Lymphoid tissue; Supervised treatment interruption

Indexed keywords

CYTOKINE;

EID: 34250629262     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3280119275     Document Type: Review
Times cited : (5)

References (46)
  • 1
    • 0034727073 scopus 로고    scopus 로고
    • Immune control of HIV-1 after early treatment of acute infection
    • Rosenberg ES, Altfeld M, Poon SH, et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000; 407:523-526.
    • (2000) Nature , vol.407 , pp. 523-526
    • Rosenberg, E.S.1    Altfeld, M.2    Poon, S.H.3
  • 2
    • 0034711393 scopus 로고    scopus 로고
    • Control of SIV rebound through structured treatment interruptions during early infection
    • Lori F, Lewis MG, Xu J, et al. Control of SIV rebound through structured treatment interruptions during early infection. Science 2000; 290:1591-1593.
    • (2000) Science , vol.290 , pp. 1591-1593
    • Lori, F.1    Lewis, M.G.2    Xu, J.3
  • 3
    • 0028909872 scopus 로고
    • Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion
    • Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122:573-579.
    • (1995) Ann Intern Med , vol.122 , pp. 573-579
    • Mellors, J.W.1    Kingsley, L.A.2    Rinaldo Jr, C.R.3
  • 4
    • 0030070991 scopus 로고    scopus 로고
    • Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
    • Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-1170.
    • (1996) Science , vol.272 , pp. 1167-1170
    • Mellors, J.W.1    Rinaldo Jr, C.R.2    Gupta, P.3
  • 5
    • 0037007670 scopus 로고    scopus 로고
    • HIV preferentially infects HIV-specific CD4+ T cells
    • Douek DC, Brenchley JM, Betts MR, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002; 417:95-98.
    • (2002) Nature , vol.417 , pp. 95-98
    • Douek, D.C.1    Brenchley, J.M.2    Betts, M.R.3
  • 6
    • 15744361847 scopus 로고    scopus 로고
    • Limited durability of viral control following treated acute HIV infection
    • Kaufmann DE, Lichterfeld M, Altfeld M, et al. Limited durability of viral control following treated acute HIV infection. PLoS Med 2004; 1:e36.
    • (2004) PLoS Med , vol.1
    • Kaufmann, D.E.1    Lichterfeld, M.2    Altfeld, M.3
  • 7
    • 0036720475 scopus 로고    scopus 로고
    • Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination
    • Markowitz M, Jin X, Hurley A, et al. Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination. J Infect Dis 2002; 186:634-643.
    • (2002) J Infect Dis , vol.186 , pp. 634-643
    • Markowitz, M.1    Jin, X.2    Hurley, A.3
  • 8
    • 33748428894 scopus 로고    scopus 로고
    • Hecht FM, Wang L, Collier A, et al. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis 2006; 194:725-733. This study of a large number of individuals identified during acute infection shows a significant, although limited, benefit of the treatment of acute HIV infection on the viral load and CD4 T-cell count.
    • Hecht FM, Wang L, Collier A, et al. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis 2006; 194:725-733. This study of a large number of individuals identified during acute infection shows a significant, although limited, benefit of the treatment of acute HIV infection on the viral load and CD4 T-cell count.
  • 9
    • 33748433647 scopus 로고    scopus 로고
    • Streeck H, Jessen H, Alter G, et al. Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection. J Infect Dis 2006; 194:734-739. This study of subjects diagnosed during acute HIV that either underwent HIV therapy or stayed without treatment does not show a benefit of early treatment in terms of viral load and CD4 cell count once therapy is interrupted.
    • Streeck H, Jessen H, Alter G, et al. Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection. J Infect Dis 2006; 194:734-739. This study of subjects diagnosed during acute HIV that either underwent HIV therapy or stayed without treatment does not show a benefit of early treatment in terms of viral load and CD4 cell count once therapy is interrupted.
  • 10
    • 17844374605 scopus 로고    scopus 로고
    • Mattapallil JJ, Douek DC, Hill B, et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434:1093-1097. This study demonstrates the massive destruction of CD4 memory T cells in the lymphoid tissue through direct viral infection during acute retroviral infection.
    • Mattapallil JJ, Douek DC, Hill B, et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434:1093-1097. This study demonstrates the massive destruction of CD4 memory T cells in the lymphoid tissue through direct viral infection during acute retroviral infection.
  • 11
    • 17844376742 scopus 로고    scopus 로고
    • Li Q, Duan L, Estes JD, et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005; 434:1148-1152. This report demonstrates the infection of resting memory CD4 T cells in mucosal tissues, and provides data supporting the concept of the destruction of CD4 T cells by both direct infection and apoptosis of uninfected cells.
    • Li Q, Duan L, Estes JD, et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005; 434:1148-1152. This report demonstrates the infection of resting memory CD4 T cells in mucosal tissues, and provides data supporting the concept of the destruction of CD4 T cells by both direct infection and apoptosis of uninfected cells.
  • 12
    • 27644513772 scopus 로고    scopus 로고
    • Beignon AS, McKenna K, Skoberne M, et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005; 115:3265-3275. This study demonstrates that HIV-1 RNA can directly activate plasmacytoid dendritic cells through interaction with Toll-like receptors.
    • Beignon AS, McKenna K, Skoberne M, et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005; 115:3265-3275. This study demonstrates that HIV-1 RNA can directly activate plasmacytoid dendritic cells through interaction with Toll-like receptors.
  • 13
    • 21644488003 scopus 로고    scopus 로고
    • Reynolds MR, Rakasz E, Skinner PJ, et al. CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little. J Virol 2005; 79:9228-9235. This study demonstrates that antiviral CTL responses appear after the extensive destruction of CD4 T cells in the lymphoid tissue.
    • Reynolds MR, Rakasz E, Skinner PJ, et al. CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little. J Virol 2005; 79:9228-9235. This study demonstrates that antiviral CTL responses appear after the extensive destruction of CD4 T cells in the lymphoid tissue.
  • 14
    • 0032540418 scopus 로고    scopus 로고
    • Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection
    • Veazey RS, DeMaria M, Chalifoux LV, et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 1998; 280:427-431.
    • (1998) Science , vol.280 , pp. 427-431
    • Veazey, R.S.1    DeMaria, M.2    Chalifoux, L.V.3
  • 15
    • 0031903088 scopus 로고    scopus 로고
    • Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4(+) T-cell depletion in primary simian immunodeficiency virus infection
    • Mattapallil JJ, Smit-McBride Z, McChesney M, Dandekar S. Intestinal intraepithelial lymphocytes are primed for gamma interferon and MIP-1beta expression and display antiviral cytotoxic activity despite severe CD4(+) T-cell depletion in primary simian immunodeficiency virus infection. J Virol 1998; 72:6421-6429.
    • (1998) J Virol , vol.72 , pp. 6421-6429
    • Mattapallil, J.J.1    Smit-McBride, Z.2    McChesney, M.3    Dandekar, S.4
  • 16
    • 4644342929 scopus 로고    scopus 로고
    • CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
    • Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-759.
    • (2004) J Exp Med , vol.200 , pp. 749-759
    • Brenchley, J.M.1    Schacker, T.W.2    Ruff, L.E.3
  • 17
    • 0142092389 scopus 로고    scopus 로고
    • Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy
    • Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003; 77:11708-11717.
    • (2003) J Virol , vol.77 , pp. 11708-11717
    • Guadalupe, M.1    Reay, E.2    Sankaran, S.3
  • 18
    • 4644289983 scopus 로고    scopus 로고
    • Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract
    • Mehandru S, Poles MA, Tenner-Racz K, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004; 200:761-770.
    • (2004) J Exp Med , vol.200 , pp. 761-770
    • Mehandru, S.1    Poles, M.A.2    Tenner-Racz, K.3
  • 19
    • 0033524838 scopus 로고    scopus 로고
    • Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
    • Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999; 283:857-860.
    • (1999) Science , vol.283 , pp. 857-860
    • Schmitz, J.E.1    Kuroda, M.J.2    Santra, S.3
  • 20
    • 0033559648 scopus 로고    scopus 로고
    • Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques
    • Jin X, Bauer DE, Tuttleton SE, et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999; 189:991-998.
    • (1999) J Exp Med , vol.189 , pp. 991-998
    • Jin, X.1    Bauer, D.E.2    Tuttleton, S.E.3
  • 21
    • 0028337166 scopus 로고
    • Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
    • Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994; 68:4650-4655.
    • (1994) J Virol , vol.68 , pp. 4650-4655
    • Koup, R.A.1    Safrit, J.T.2    Cao, Y.3
  • 22
    • 0028041344 scopus 로고
    • Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection
    • Borrow P, Lewicki H, Hahn BH, et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994; 68:6103-6110.
    • (1994) J Virol , vol.68 , pp. 6103-6110
    • Borrow, P.1    Lewicki, H.2    Hahn, B.H.3
  • 23
    • 0037432736 scopus 로고    scopus 로고
    • Immunology CD8 T cells remember with a little help
    • Kaech SM, Ahmed R. Immunology CD8 T cells remember with a little help. Science 2003; 300:263-265.
    • (2003) Science , vol.300 , pp. 263-265
    • Kaech, S.M.1    Ahmed, R.2
  • 24
    • 0037103201 scopus 로고    scopus 로고
    • Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection
    • Harari A, Rizzardi GP, Ellefsen K, et al. Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Blood 2002; 100:1381-1387.
    • (2002) Blood , vol.100 , pp. 1381-1387
    • Harari, A.1    Rizzardi, G.P.2    Ellefsen, K.3
  • 25
    • 23944431912 scopus 로고    scopus 로고
    • Zaunders J, Munier ML, Kaufmann DE, et al. Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection. Blood 2005; 106:1660-1667. This study provides a detailed functional and phenotypic characterization of HIV-specific CD4 T cells during acute HIV infection.
    • Zaunders J, Munier ML, Kaufmann DE, et al. Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection. Blood 2005; 106:1660-1667. This study provides a detailed functional and phenotypic characterization of HIV-specific CD4 T cells during acute HIV infection.
  • 26
    • 11844306664 scopus 로고    scopus 로고
    • Harari A, Vallelian F, Meylan PR, Pantaleo G. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol 2005; 174:1037-1045. This paper demonstrated that the functional heterogeneity in terms of cytokine secretion of antigen-specific CD4 T cells correlates with antigen load and persistence.
    • Harari A, Vallelian F, Meylan PR, Pantaleo G. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol 2005; 174:1037-1045. This paper demonstrated that the functional heterogeneity in terms of cytokine secretion of antigen-specific CD4 T cells correlates with antigen load and persistence.
  • 27
    • 0347382593 scopus 로고    scopus 로고
    • Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells
    • Kaech SM, Tan JT, Wherry EJ, et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4:1191-1198.
    • (2003) Nat Immunol , vol.4 , pp. 1191-1198
    • Kaech, S.M.1    Tan, J.T.2    Wherry, E.J.3
  • 28
    • 0035923542 scopus 로고    scopus 로고
    • High-level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation
    • McNeil AC, Shupert WL, Iyasere CA, et al. High-level HIV-1 viremia suppresses viral antigen-specific CD4+ T cell proliferation. Proc Natl Acad Sci U S A 2001; 98:13878-13883.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 13878-13883
    • McNeil, A.C.1    Shupert, W.L.2    Iyasere, C.A.3
  • 29
    • 0141677716 scopus 로고    scopus 로고
    • Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2
    • Iyasere CA, Tilton JC, Johnson AJ, et al. Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J Virol 2003; 77:10900-10909.
    • (2003) J Virol , vol.77 , pp. 10900-10909
    • Iyasere, C.A.1    Tilton, J.C.2    Johnson, A.J.3
  • 30
    • 0347911962 scopus 로고    scopus 로고
    • HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity
    • Younes SA, Yassine-Diab B, Dumont AR, et al. HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med 2003; 198:1909-1922.
    • (2003) J Exp Med , vol.198 , pp. 1909-1922
    • Younes, S.A.1    Yassine-Diab, B.2    Dumont, A.R.3
  • 31
    • 0036192919 scopus 로고    scopus 로고
    • Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy
    • Rizzardi GP, Harari A, Capiluppi B, et al. Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy. J Clin Invest 2002; 109:681-688.
    • (2002) J Clin Invest , vol.109 , pp. 681-688
    • Rizzardi, G.P.1    Harari, A.2    Capiluppi, B.3
  • 32
    • 0038205695 scopus 로고    scopus 로고
    • Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection
    • Alter G, Hatzakis G, Tsoukas CM, et al. Longitudinal assessment of changes in HIV-specific effector activity in HIV-infected patients starting highly active antiretroviral therapy in primary infection. J Immunol 2003; 171:477-488.
    • (2003) J Immunol , vol.171 , pp. 477-488
    • Alter, G.1    Hatzakis, G.2    Tsoukas, C.M.3
  • 33
    • 0035862330 scopus 로고    scopus 로고
    • Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
    • Altfeld M, Rosenberg ES, Shankarappa R, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 2001; 193:169-180.
    • (2001) J Exp Med , vol.193 , pp. 169-180
    • Altfeld, M.1    Rosenberg, E.S.2    Shankarappa, R.3
  • 34
    • 0032728214 scopus 로고    scopus 로고
    • Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection
    • Dalod M, Dupuis M, Deschemin JC, et al. Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection. J Clin Invest 1999; 104:1431-1439.
    • (1999) J Clin Invest , vol.104 , pp. 1431-1439
    • Dalod, M.1    Dupuis, M.2    Deschemin, J.C.3
  • 35
    • 4644249757 scopus 로고    scopus 로고
    • Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells
    • Lichterfeld M, Kaufmann DE, Yu XG, et al. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med 2004; 200:701-712.
    • (2004) J Exp Med , vol.200 , pp. 701-712
    • Lichterfeld, M.1    Kaufmann, D.E.2    Yu, X.G.3
  • 36
    • 23044447269 scopus 로고    scopus 로고
    • Jansen CA, De Cuyper IM, Steingrover R, et al. Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions. AIDS 2005; 19:1145-1154. This report shows that the augmentation of HIV-specific CD4 T-cell responses after the treatment of acute HIV infection did not correlate with enhanced viral control after treatment interruption.
    • Jansen CA, De Cuyper IM, Steingrover R, et al. Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions. AIDS 2005; 19:1145-1154. This report shows that the augmentation of HIV-specific CD4 T-cell responses after the treatment of acute HIV infection did not correlate with enhanced viral control after treatment interruption.
  • 37
    • 32644442808 scopus 로고    scopus 로고
    • Jansen CA, De Cuyper IM, Hooibrink B, et al. Prognostic value of HIV-1 Gag-specific CD4+ T-cell responses for progression to AIDS analyzed in a prospective cohort study. Blood 2006; 107:1427-1433. This large cohort study demonstrates that the magnitude HIV-specific CD4 T-cell responses assessed by cytokine secretion and proliferation assays early after acute HIV infection were not predictive of disease progression.
    • Jansen CA, De Cuyper IM, Hooibrink B, et al. Prognostic value of HIV-1 Gag-specific CD4+ T-cell responses for progression to AIDS analyzed in a prospective cohort study. Blood 2006; 107:1427-1433. This large cohort study demonstrates that the magnitude HIV-specific CD4 T-cell responses assessed by cytokine secretion and proliferation assays early after acute HIV infection were not predictive of disease progression.
  • 38
    • 27744561661 scopus 로고    scopus 로고
    • Seth N, Kaufmann D, Lahey T, et al. Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication. J Immunol 2005; 175:6948-6958. A detailed characterization of HIV-specific CD4 T-cell responses after acute infection using class II tetramers.
    • Seth N, Kaufmann D, Lahey T, et al. Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication. J Immunol 2005; 175:6948-6958. A detailed characterization of HIV-specific CD4 T-cell responses after acute infection using class II tetramers.
  • 39
    • 0036852179 scopus 로고    scopus 로고
    • HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors
    • Migueles SA, Laborico AC, Shupert WL, et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002; 3:1061-1068.
    • (2002) Nat Immunol , vol.3 , pp. 1061-1068
    • Migueles, S.A.1    Laborico, A.C.2    Shupert, W.L.3
  • 41
    • 4043060710 scopus 로고    scopus 로고
    • Correlates of immune protection in HIV-1 infection: What we know, what we don't know, what we should know
    • Pantaleo G, Koup RA. Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat Med 2004; 10:806-810.
    • (2004) Nat Med , vol.10 , pp. 806-810
    • Pantaleo, G.1    Koup, R.A.2
  • 42
    • 1642500367 scopus 로고    scopus 로고
    • Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: Changes after antiretroviral therapy
    • Harari A, Petitpierre S, Vallelian F, Pantaleo G. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 2004; 103:966-972.
    • (2004) Blood , vol.103 , pp. 966-972
    • Harari, A.1    Petitpierre, S.2    Vallelian, F.3    Pantaleo, G.4
  • 43
    • 20144384850 scopus 로고    scopus 로고
    • Betts MR, Exley B, Price DA, et al. Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proc Natl Acad Sci U S A 2005; 102:4512-4517. This report investigates the changes in the characteristics of the HIV-specific T cells in a vaccinated subject who subsequently became infected by HIV.
    • Betts MR, Exley B, Price DA, et al. Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection. Proc Natl Acad Sci U S A 2005; 102:4512-4517. This report investigates the changes in the characteristics of the HIV-specific T cells in a vaccinated subject who subsequently became infected by HIV.
  • 44
    • 23244463710 scopus 로고    scopus 로고
    • Kinloch-de Loes S, Hoen B, Smith DE, et al. Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection. J Infect Dis 2005; 192:607-617. This study describes the lack of effect of an adjuvant immunotherapy in treated acute HIV infection (QUEST study).
    • Kinloch-de Loes S, Hoen B, Smith DE, et al. Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection. J Infect Dis 2005; 192:607-617. This study describes the lack of effect of an adjuvant immunotherapy in treated acute HIV infection (QUEST study).
  • 45
    • 33744990609 scopus 로고    scopus 로고
    • Letvin NL, Mascola JR, Sun Y, et al. Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 2006; 312:1530-1533. This study demonstrates that vaccine-generated pre-existing SIV-specific immunity can improve survival after SIV infection, and that this benefit correlates with the preservation of the central memory CD4 T-cell count and with vaccine-induced CD4 and CD8 T-cell responses in peripheral blood.
    • Letvin NL, Mascola JR, Sun Y, et al. Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 2006; 312:1530-1533. This study demonstrates that vaccine-generated pre-existing SIV-specific immunity can improve survival after SIV infection, and that this benefit correlates with the preservation of the central memory CD4 T-cell count and with vaccine-induced CD4 and CD8 T-cell responses in peripheral blood.
  • 46
    • 33745015013 scopus 로고    scopus 로고
    • Mattapallil JJ, Douek DC, Buckler-White A, et al. Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge. J Exp Med 2006; 203:1533-1541. This report shows that vaccine-generated pre-existing simian immunodeficiency virus-specific immunity can improve survival after simian immunodeficiency virus infection and that this benefit correlates with the preservation of the central memory CD4 T-cell population in various lymphoid tissues and with vaccine-induced CD4 and CD8 T-cell responses.
    • Mattapallil JJ, Douek DC, Buckler-White A, et al. Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge. J Exp Med 2006; 203:1533-1541. This report shows that vaccine-generated pre-existing simian immunodeficiency virus-specific immunity can improve survival after simian immunodeficiency virus infection and that this benefit correlates with the preservation of the central memory CD4 T-cell population in various lymphoid tissues and with vaccine-induced CD4 and CD8 T-cell responses.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.